Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-25

Clinical Trial Update: The Effect of Antacids and Multivitamins on Raltegravir [Phase 1]

View source ↗

Summary

Phase 1 study evaluating potential interactions between antacids and multivitamins and the HIV antiretroviral raltegravir.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isentress (Raltegravir)

Snippet

Sponsor: Helen Reynolds | Conditions: HIV | Phase 1 | Status: COMPLETED